Imprimis Pharma (IMMY)

2.78 -0.02 (0.71%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/9/18 *Est.)

Latest Headlines

Form SC 13G Imprimis Pharmaceuticals Filed by: Opaleye Management Inc. September 7, 2018 5:26 PM - SEC Filing Form 4 Imprimis Pharmaceuticals For: Sep 04 Filed by: Kammer Robert J September 5, 2018 7:46 PM - SEC Filing Form 4 Imprimis Pharmaceuticals For: Aug 10 Filed by: Kammer Robert J August 15, 2018 6:32 AM - SEC Filing Form 8-K Imprimis Pharmaceuticals For: Aug 10 August 13, 2018 6:16 AM - SEC Filing Form 8-K Imprimis Pharmaceuticals For: Aug 08 August 8, 2018 7:04 AM - SEC Filing Form 8-K Imprimis Pharmaceuticals For: Aug 06 August 6, 2018 4:21 PM - SEC Filing Form 10-Q Imprimis Pharmaceuticals For: Jun 30 August 6, 2018 4:20 PM - SEC Filing Imprimis Pharmaceuticals Announces Second Quarter 2018 Results August 6, 2018 4:01 PM - PR NewsWire Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi™ (Triamcinolone Acetonide-Moxifloxacin for injection) Formulation in Canada August 1, 2018 7:31 AM - PR NewsWire Imprimis Pharmaceuticals to Announce Second Quarter 2018 Financial Results on August 6, 2018 July 31, 2018 7:30 AM - Globe NewsWire Form 8-K Imprimis Pharmaceuticals For: Jul 24 July 25, 2018 7:31 AM - SEC Filing Imprimis Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference on August 9, 2018 July 18, 2018 7:30 AM - PR NewsWire Form 4 Imprimis Pharmaceuticals For: Jun 29 Filed by: LINDSTROM RICHARD L MD July 2, 2018 7:53 PM - SEC Filing Form 4 Imprimis Pharmaceuticals For: Jun 29 Filed by: Kammer Robert J July 2, 2018 7:49 PM - SEC Filing Form 4 Imprimis Pharmaceuticals For: Jun 29 Filed by: Principi Anthony July 2, 2018 7:48 PM - SEC Filing Form 4 Imprimis Pharmaceuticals For: Jun 29 Filed by: AUSTIN STEPHEN G July 2, 2018 7:44 PM - SEC Filing Form 8-K Imprimis Pharmaceuticals For: Jun 28 July 2, 2018 5:25 PM - SEC Filing Full Article List